Similarly, among a cohort of individuals with T2DM well controlled with sulfonylurea, 4 probands carried ABCC8 mutations, of which 2 variants were likely causal, the others putatively representing rare benign variants [17]. The gene discussed is ABCC8; the disease is type 2 diabetes mellitus.